MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12350-019-01976-6

Медицинская библиотека · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019

18F-FMISO PET/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis.

Furuya Sho, Naya Masanao, Manabe Osamu, Hirata Kenji, Ohira Hiroshi, Aikawa Tadao, Koyanagawa Kazuhiro, Magota Keiichi, Tsujino Ichizo, Anzai Toshihisa, Kuge Yuji, Oyama-Manabe Noriko, Kudo Kohsuke, Shiga Tohru, Tamaki Nagara

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

18F-fluoromisonidazole (FMISO) is a hypoxia positron emission tomography (PET) tracer. Here, we evaluated cardiac and extra-cardiac sarcoidosis using both FMISO and 18F-fluorodeoxyglucose (FDG) PET/CT in a prospective cohort of patients with sarcoidosis.

METHODS

Ten consecutive sarcoidosis patients with suspected cardiac involvement were prospectively enrolled. Each patient fasted overnight (for ≥ 18 hours) preceded by a low-carbohydrate diet before FDG PET/CT but not given special dietary instructions before the FMISO PET/CT scan. We visually and semiquantitatively assessed the uptakes of FMISO and FDG using the maximal standardized uptake value (SUVmax). The metabolic volume (MV) of FDG was calculated as the volume within the boundary determined by the threshold (mean SUV of blood pool × 1.5).

RESULTS

Nine patients showed focal FDG uptake in the myocardium and were diagnosed with cardiac sarcoidosis. Among the patients with extra-cardiac lesions, FDG uptake was seen in 8 lymph nodes and 3 lung lesions. FMISO uptake was seen in the 7 cardiac (77.8%) and 6 extra-cardiac (54.5%) lesions. None of the patients showed physiological FMISO uptake in the myocardium. The SUVmax values of the lesions with FMISO uptake were higher than those of the lesions without FMISO uptake in both the cardiac (SUVmax: 9.9, IQR: 8.4-10.0 vs 7.3, IQR: 6.3-8.2) and non-cardiac lesions (SUVmax: 17.6, IQR: 14.5-19.3 vs 6.1, IQR: 5.9-6.2; P = 0.006). The MV values of the lesions with FMISO uptake were significantly higher than those of the lesions without FMISO uptake (111.3, IQR: 78.3-135.7 vs 6.4, IQR: 1.9-23.3; P = 0.0009).

CONCLUSIONS

FMISO showed no physiological myocardial uptake and did not require special preparation. FMISO PET has the potential to detect hypoxic lesions in patients with sarcoidosis.

Для цитирования: Furuya Sho, Naya Masanao, Manabe Osamu, Hirata Kenji, Ohira Hiroshi, Aikawa Tadao, Koyanagawa Kazuhiro, Magota Keiichi, Tsujino Ichizo, Anzai Toshihisa, Kuge Yuji, Oyama-Manabe Noriko, Kudo Kohsuke, Shiga Tohru, Tamaki Nagara. 18F-FMISO PET/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis.. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. 2019. DOI: 10.1007/s12350-019-01976-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.